Michael Hill

机构：University of Oxford · ORCID：0000-0002-3861-6105

发表论文 186 篇 · 总被引 14401 次 · h-index 49

代表论文

• Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial (2023 · The Lancet Diabetes & Endocrinology · 被引 117)
• Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial (2023 · The Lancet Diabetes & Endocrinology · 被引 94)
• Comparative studies of 2168 plasma proteins measured by two affinity-based platforms in 4000 Chinese adults (2025 · Nature Communications · 被引 55)
• Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease (2023 · Journal of the American College of Cardiology · 被引 44)
• Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes (2024 · Diabetes Care · 被引 35)
• Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study (2025 · Circulation · 被引 19)